Mingxiu Hu, PhD

Mingxiu Hu is currently Senior Vice President at Nektar Therapeutics responsible for Data Science and Systems. Before joining Nektar, Dr. Hu was a Vice President, Global Head of Biometrics, at Takeda Pharmaceuticals. Prior to Takeda, he spent seven years at Pfizer. He is an Adjunct Professor of Biostatistics at the Yale School of Public Health and a Fellow of the American Statistical Association (ASA), and served on the Board of Directors, Executive Committee, and Fellow Selection Committee for ASA. He is a leader in innovative clinical trial designs and had featured in PharmaVoice magazine multiple times on this topic. His research interest focuses on statistical methodologies and applications in drug development, including clinical trial designs and analysis methodologies, development decision making, and biomarker strategies. He has published over 20 scientific articles, edited one book, and co-authored another.

Dr. Hu received his Ph.D in Statistics from George Washington University, M.S. in Statistics from Beijing University, and M.A. in Biology from Brown University.